Artificial intelligence models in primary care: performance, transparency, and safety in patient triage
Artificial intelligence models in primary care: performance, transparency, and safety in patient triage
DOI:
https://doi.org/10.51473/rcmos.v1i1.2023.1851Keywords:
artificial intelligence in healthcare; primary care; clinical governance; medical ethics; automated triage; emergency care.Abstract
The incorporation of artificial intelligence (AI) into health systems has significantly progressed in recent years, expanding into non-hospital settings such as primary care and emergency services. This article critically analyzes international experiences (United States, Canada, United Kingdom, and Brazil) involving AI applications for automated triage, risk stratification, and clinical decision support, with a focus on low- and medium-complexity healthcare settings. It outlines key risks associated with these technologies—algorithmic bias, opacity, interoperability failures, data governance weaknesses, and privacy issues—in light of international regulatory and ethical frameworks proposed by institutions such as the World Health Organization (WHO), the Food and Drug Administration (FDA), and the National Institute for Health and Care Excellence (NICE). Based on this analysis, the article proposes a set of minimum criteria for the safe and ethical implementation of AI in primary care and emergency contexts, including local clinical validation, transparency, bias control, data governance, systemic integration, staff training, and post-deployment monitoring. It concludes that AI can strengthen primary care, improve patient flow management, and support complex clinical decisions, provided it is implemented under robust clinical governance, with continuous professional oversight and full respect for patients’ rights.
Downloads
References
ORGANIZAÇÃO MUNDIAL DA SAÚDE. Ética e governança da inteligência artificial para a saúde. Genebra: World Health Organization, 2021.
FOOD AND DRUG ADMINISTRATION. Proposed regulatory framework for modifications to AI/ML-based software as a medical device (SaMD): discussion paper and request for feedback. Silver Spring: FDA, 2019.
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Evidence standards framework for digital health technologies. Londres: NICE, 2021.
BRASIL. Ministério da Saúde. TAMIS-IA: iniciativa nacional para inteligência artificial em saúde. Brasília: DATASUS, 2023.
PEREIRA, J. P.; DINIZ, M. A. A.; LIMA, J. G. Inteligência artificial em saúde: riscos éticos e perspectivas para o SUS. Revista Bioética, v. 30, n. 2, p. 264-273, 2022.
SHORTLIFFE, E. H.; SEPÚLVEDA, M. J. Clinical decision support in the era of artificial intelligence. JAMA, v. 320, n. 21, p. 2199-2200, 2018. DOI: https://doi.org/10.1001/jama.2018.17163
OBERMEYER, Z. et al. Dissecting racial bias in an algorithm used to manage the health of populations. Science, v. 366, n. 6464, p. 447-453, 2019. DOI: https://doi.org/10.1126/science.aax2342
TOPOL, E. Deep medicine: how artificial intelligence can make healthcare human again. Nova York: Basic Books, 2019.
RAJKOMAR, A.; DEAN, J.; KOHANE, I. Machine learning in medicine. New England Journal of Medicine, v. 380, p. 1347-1358, 2019. DOI: https://doi.org/10.1056/NEJMra1814259
SILVA, A.; CARVALHO, D. B.; FARIA, L. F. Interoperabilidade em saúde: desafios e perspectivas para a adoção da IA no SUS. Cadernos de Saúde Pública, v. 37, n. 4, 2021. DOI: https://doi.org/10.1590/0102-311x00035321
IBM WATSON HEALTH. Transparency and trust in AI for health. Whitepaper. IBM, 2021.
DISTRITO FEDERAL. Secretaria de Saúde. TAMIS: triagem avançada médica com IA no SUS. Brasília, 2023.
WORLD ECONOMIC FORUM. AI governance in healthcare: ethical and legal challenges. Genebra: WEF, 2020.
EUROPEAN COMMISSION. Proposal for a regulation on artificial intelligence. Bruxelas: European Union, 2021.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2023 Lucas Pedroza Daniel (Autor)

This work is licensed under a Creative Commons Attribution 4.0 International License.




